From Concept to Policy: Pull Funding for Repurposed Generic Drugs

Repurposing existing generic drugs could expand treatment options and reduce healthcare costs. However, current market and regulatory structures discourage investment in this area. This paper proposes a “pull funding” model as a policy solution to create stronger incentives for developing and adopting repurposed generics, and covers the following: 

• Exploring the current landscape of generic drug repurposing and the market failure
• Designing a pull funding model that rewards impactful drug repurposing
• Implementing a pull funding mechanism in tandem with supportive policies and programs

Repurposed generic drugs represent one of the most overlooked opportunities in public health—and the time to act is now. Unlocking their potential will require bold policy innovation and new incentive models that reward proven impact. The proposed pull funding approach offers a clear, results-driven path to bridge the gap between discovery and real-world adoption. To understand how this framework can be implemented and scaled to deliver lasting change, dive into the full paper and join the effort to make repurposed generics a cornerstone of accessible, affordable health care.